Toxicokinetic Modeling as a Tool for Risk Estimation: 2,3,7,8-Tetrachlorodibenzo-P-Dioxin
- 1 July 1997
- journal article
- research article
- Published by SAGE Publications in International Journal of Toxicology
- Vol. 16 (4-5) , 433-448
- https://doi.org/10.1080/109158197227053
Abstract
Concepts of toxicokinetic modeling and the relevance of toxicokinetics for understanding dose-response relationships, species scaling, and risk estimation are broached. A physiological one-compartment model for 2,3,7,8-tetra-chlorodibenzo-p-dioxin (TCDD) is presented in detail. It describes the TCDD burden of the human body, which results from TCDD-contaminated food, in dependence of age. The model was validated using a series of measured values obtained by other authors and this group. They represent lipid-based concentrations of TCDD in liver, blood, adipose tissue, feces, and mother's milk in dependence of age. Special attention was paid to the TCDD burden in infants resulting from feeding with mother's milk or formula. Model simulations demonstrate that TCDD burden can amount to 10 mg/kg of lipids after nursing for 6 months with mother's milk exclusively This is still within the range of the concentrations found in adults. After the nursing period, TCDD burden declines. From the age of 7 years on, there is no longer a difference in the TCDD burden, independently of the food they had received as infants. According to the model, elimination half-life of TCDD from the body is not constant but increases during life starting from a few months in newborns to several years in adults.Keywords
This publication has 32 references indexed in Scilit:
- Functional aspects of developmental toxicity of polyhalogenated aromatic hydrocarbons in experimental animals and human infantsEuropean Journal of Pharmacology: Environmental Toxicology and Pharmacology, 1995
- Modeling of the Toxicokinetics of Polychlorinated Dibenzo-p-dioxins and Dibenzofurans in Mammalians, Including Humans: I. Nonlinear Distribution of PCDD/PCDF Body Burden between Liver and Adipose TissuesToxicology and Applied Pharmacology, 1995
- Modeling of the Toxicokinetics of Polychlorinated Dibenzo-p-dioxins and Dibenzofurans in Mammalians, Including Humans: II. Kinetics of Absorption and Disposition of PCDDs/PCDFsToxicology and Applied Pharmacology, 1995
- Intake and fecal excretion of PCDDs, PCDFs, HCB and PCBs (138, 153, 180) in a breast-fed and a formula-fed infantChemosphere, 1994
- A physiologic pharmacokinetic model for styrene and styrene-7,8-oxide in mouse, rat and manArchives of Toxicology, 1994
- Modeling Receptor‐Mediated Processes with Dioxin: Implications for Pharmacokinetics and Risk AssessmentRisk Analysis, 1993
- PCDD and PCDF concentrations in different organs from infantsChemosphere, 1990
- PCDD and PCDF levels in human milk - dependence on the period of lactationChemosphere, 1989
- PCDD and PCDF body burden from food intake in the Federal Republic of GermanyChemosphere, 1989
- Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxinArchives of Toxicology, 1988